GWest Corporation Limited

—

What it is

GWest Corporation develops commercial properties and provides healthcare services in Jamaica, operating medical facilities that cover urgent care, heart and renal services, surgery, radiology, MRI, dentistry, laboratory, pharmacy, and specialist consultations.

The company was incorporated on December 3, 2007, and built its flagship asset — a medical and dental complex on lands at Fairview, Montego Bay. The land was acquired around 2009, and construction broke ground in 2014.

GWest became the 34th company to list on the JSE Junior Market, and the seventh to do so in 2017. The IPO sold roughly 35% of the company to the public, floating 169.69 million shares at JMD 2.50 (US$0.02)each.

The business has two engines: renting clinic suites to independent doctors and health businesses at the GWest Centre, and running its own direct medical services. In the year to March 2025, cost of sales fell 9% to JMD 184.7m (US$1 mn), and gross profit rose 14% to JMD 83.2m (US$529 k) — the building’s economics are improving even as the overall bottom line remains in the red.

—

Who owns it

The company’s founders include medical and business professionals: Dr. Konrad Kirlew, Wayne Gentles, Dr. Ladi Doonquah, Elva Williams-Richards, Dennis Samuels, and Denise Samuels. At the time of the 2017 IPO, Kirlew controlled 30% through two vehicles (Radiology West 20%, North Coast Imaging 10%); the Samuels family also held 30%; Dr. Doonquah held 20%; and Gentles’s firm Bull Investments and Williams-Richards each held 10%.

The IPO diluted those stakes by roughly 35%, bringing in public shareholders. The current precise split among founders is not disclosed in available post-IPO sources, but the founding group collectively retained the majority position.

The total shares in issue stand at 484,848,485.

—

Who runs it

Wayne Wray was appointed to the board in March 2023 and serves as Chairman. Wayne Gentles, the finance director who is also a co-founder, holds the role of executive director with overall management responsibility.

Gentles is also a major shareholder through his investment management firm, Bull Investments — a rare combination of owner, financier, and operator in one person. Dr. Konrad Kirlew resigned from the board effective March 30, 2023.

—

The money, in plain words

In the financial year ended March 31, 2025, GWest brought in JMD 267.9m (≈ USD 1.70m) in revenue — a 3% drop from JMD 277.1m (US$2 mn) the year before. At a net loss of JMD 35.2m (US$224 k), the net margin was –13.1% (our calculation): for every dollar of sales, it lost about 13 cents after all costs.

Shareholders’ equity — the net worth belonging to owners — stood at JMD 667.9m (≈ USD 4.25m), or a book value per share of JMD 1.38. (US$0.01)The share trades at JMD 0.85, m (US$5 k)eaning investors pay about 62 cents for every dollar of stated net asset value — a price-to-book of 0.62× (our calculation), reflecting the market’s scepticism about near-term profitability.

Total assets fell to JMD 1.66bn (≈ USD 10.6m), mainly because the value of the investment properties on the books slipped 8% to JMD 668.5m (US$4 mn) and the right-of-use assets declined 16% to JMD 294.1m (US$2 mn). No dividend has been paid.

Other gains — mostly property revaluations — collapsed 55% to JMD 18.6m (US$118 k), which is a big part of why the full-year loss widened even as the underlying gross profit improved.

—

What it is doing now

GWest filed its audited financial statements for the year ended March 31, 2025 with the Jamaica Stock Exchange, and its Annual General Meeting — originally scheduled for November 10, 2025 — was postponed after severe disruption from Hurricane Melissa. The AGM was rescheduled to December 1, 2025, at Unit 34 GWest Centre.

In the nine months to December 31, 2024, revenue was already running 12% ahead year-on-year at JMD 202.6m (US$1 mn), signalling a stronger revenue trend before the weak final quarter pulled the full year down 3%. The FY2026 trajectory will be the key test of whether that momentum holds.

—

What to watch

• Revenue trend: The nine-month figure looked healthy; the Q4 drop of 32% in revenue was sharp. Investors need to see whether Q4 weakness was a one-off or the start of a new problem.
• Property values: Most of GWest’s assets sit in investment properties and right-of-use assets. An 8% decline in investment property value to JMD 668.5m (US$4 mn) in FY2025 reduced the balance sheet and squeezed equity — further declines would hurt the book value per share.
• Path to profit: Earnings have declined by 52% per year over the past five years. The gross margin is actually improving; the question is whether higher occupancy and partnership revenue can cover the fixed overhead.
• Leadership continuity: Wayne Gentles wears three hats — co-founder, major shareholder, and executive director. Any change here would be material.
• Medical partnerships: GWest’s stated strategy is to become “a one-stop healthcare facility for Western Jamaica” through key partnerships; execution against that goal is the long-term value driver.

—

This is news, not investment advice.